Bone Marrow Suppression During Chemotherapy

Anemia, Neutropenia & Thrombocytopenia

Table of Contents
View All
Table of Contents

Bone marrow suppression refers to a decrease in the ability of the bone marrow to manufacture cells, and is common with chemotherapy. In addition to eliminating cancer cells, chemotherapy drugs eliminate normal cells that divide rapidly, such as those in the bone marrow that form the different types of blood cells. Suppression can result in a reduction in white blood cells, resulting in an increased risk of infections, in red blood cells, causing anemia and fatigue, and in platelets, increasing the risk of bleeding. Blood counts are followed closely throughout chemotherapy to watch for suppression. If present, medications may be used to increase the white blood cell count or transfusions may be given. Chemotherapy infusions may also need to be delayed or stopped, if blood counts drop too low.

Test tube filled with blood


When the bone marrow is suppressed, it is unable to supply the body with enough blood cells. Each of these types of blood cells perform very important roles in the body:

Red blood cells

The red blood cells contain hemoglobin which carries oxygen to every cell in the body, and returns carbon dioxide to the lungs to be exhaled. If there are not enough red blood cells to deliver oxygen to all of the tissues of the body, cell damage and death occurs, a process called hypoxia. A reduced level of red blood cells is referred to as anemia.

White blood cells

White blood cells (also known as leukocytes) are the defense system of our bodies, protecting us from bacteria, viruses, and other foreign substances, even cancer cells. A deficiency of white blood cells is referred to as leukopenia. With cancer, you will hear about neutropenia. Neutropenia refers to a deficiency of one particular type of white blood cell known as neutrophils. Neutrophils play a large role in protecting us from bacteria and viruses, and when there are not adequate numbers, we are predisposed to infection.


Platelets are responsible for creating blood clots. If we are deficient in platelets, our blood is not able to adequately clot when we are cut or injured. This deficiency if referred to as thrombocytopenia.

How Chemotherapy Suppresses Bone Marrow

Chemotherapy is designed to kill rapidly growing cells such as cancer cells but affects all rapidly growing cells. This includes cells in our hair follicles, gastrointestinal tract, and bone marrow. When these cells in the bone marrow are damaged, they are unable to reproduce and become the different types of blood cells.

All of the blood cells begin with a common cell known as a hematopoietic stem cell. Through a process known as hematopoiesis, the stem cells "specialize" and become of the blood cells including red blood cells, the different types of white blood cells, and platelets. Since chemotherapy drugs can kill off these "pluripotential" cells that differentiate to form the different types of blood cells, deficiencies of all of the types of blood cells usually occurs. That said, some blood cells can be affected more than others, and the impact of low levels of some can be more serious than others.


The symptoms of bone marrow suppression depend on the type of blood cells affected and will be described below under each respective type of blood cell. In general, a deficiency of blood cells results in fatigue and weakness.


Before and after chemotherapy, your healthcare provider will order a complete blood count (CBC), to see if any of your blood counts are low. Normal levels are as follows:

Red blood cells: 4.1 to 6.7 million cells/mcL for men, 4.2 to 5.4 million cells/mcL for women

White blood cells: Total WBC 4,000 to 10,000 cells/mcL

Platelet count: 150,000 to 400,000/dL

When looking at your red blood count, you are more likely to see mention of your hemoglobin or hematocrit. Ranges include:

  • Hemoglobin: 13.8 to 17.2 grams/dL for men, 12.1 to 15.1 grams/dL for women
  • Hematocrit: 40.7% to 50.3% for men, 36.1% to 44.3% for women

When looking at your white blood cell count, your oncologist will be concerned not only about your white blood cell count, but your total neutrophil count. Neutrophils are a type of blood cell that are essentially our first responders when it comes to fighting off bacterial infections.

An normal absolute neutrophil count is between 2500 and 7500 neutrophils/dL.

Chemotherapy-Induced Anemia 

A decreased level of red blood cells during chemotherapy is referred to as chemotherapy-induced anemia. When there are too few red blood cells to carry oxygen to the cells, symptoms result. Symptoms of anemia may include:

  • Fatigue
  • Lightheadedness or dizziness
  • A pale appearance
  • Shortness of breath
  • Rapid heart rate or palpitations

Depending upon the level of your red blood cells, your healthcare provider may reassure you that your anemia will improve after you are done with chemotherapy, or may recommend treatment with a medication to stimulate red blood cell production, prescribe iron supplements, or recommend a blood transfusion. Anemia is a treatable cause of fatigue, so oncologists watch closely for this during treatment. Unfortunately, there are many causes of cancer fatigue, and anemia is only one of these.

Chemotherapy-Induced Neutropenia 

A low level of the type of white blood cells known as neutrophils during chemotherapy is referred to as chemotherapy-induced neutropenia. All of the different types of white blood cells may be affected with bone marrow suppression, but suppression of the number of neutrophils is most important in raising the risk of infection. Most of the symptoms of neutropenia are related to infections that develop and may include:

  • A fever greater than 100.5 F.
  • Chills
  • Cough
  • Shortness of breath
  • Redness or drainage around an injury or entrance to the body such as a Port or IV line

During chemotherapy, your healthcare provider will advise you to avoid situations that could result in infection, such as spending time with people who are ill or shopping in crowded malls. If your white count is very low, she may recommend that your next chemotherapy treatment is delayed, or prescribe medications to help prevent infection or stimulate the production of white blood cells. Medications such as Neupogen or Neulasta are injections which stimulate the formation and release of white blood cells from the bone marrow. In some cases, they will be given routinely in order to keep your white count normal during chemotherapy.

Chemotherapy-Induced Thrombocytopenia

Since platelets are responsible for blood clotting, a low platelet count can result in bleeding. A low platelet count due to chemotherapy is referred to as chemotherapy-induced thrombocytopenia. Signs of thrombocytopenia can include:

  • Easy bruising
  • Petechiae - red spots on your skin that stay red even when you put pressure on them
  • Joint and muscle pain
  • Blood in your urine or stools
  • Heavy menstrual periods

If your platelet count is too low or you have problems with bleeding, your healthcare provider may recommend a platelet transfusion or a medication to stimulate your bone marrow to make more platelets. If you are interested, you can learn more about coping with chemotherapy-induced thrombocytopenia.

Tips for Coping 

Your healthcare team will monitor your blood counts and recommend treatment if these become too low, but there are several things you can do take care of yourself at this time:

  • Learn how to properly wash your hands - Studies tell us that the vast majority of people - even health professionals - don't wash their hands in the best way to stay safe during chemotherapy.
  • Call your healthcare provider with any signs of infection, such as a fever greater than 100.5 F, coughing, chills, shortness of breath, or pain with urination
  • Rest when you are feeling tired
  • Stand up slowly after you have been resting
  • Avoid medications such as aspirin and ibuprofen that can increase bleeding
  • Take special care to avoid situations where you could be cut or otherwise injured
Was this page helpful?
9 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31-38. doi:10.1002/ajh.24201

  2. Penn State Hersey. Milton S. Hersey Medical Center. CBC Blood Test.

  3. Whitehead L. Managing Chemotherapy-Induced Anemia with Erythropoiesis-Stimulating Agents Plus Iron. Am J Nurs. 2017;117(5):67. doi:10.1097/01.NAJ.0000516277.58981.36

  4. Mohandas H, Jaganathan SK, Mani MP, Ayyar M, Rohini Thevi GV. Cancer-related fatigue treatment: An overview. J Cancer Res Ther. 2017;13(6):916-929. doi:10.4103/jcrt.JCRT_50_17

  5. Long B, Koyfman A. Oncologic Emergencies: The Fever With Too Few Neutrophils. J Emerg Med. 2019;57(5):689-700. doi:10.1016/j.jemermed.2019.08.009

  6. Bond TC, Szabo E, Gabriel S, et al. Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events. J Oncol Pharm Pract. 2018;24(6):412-423. doi:10.1177/1078155217714859

  7. National Heart, Lung, and Blood Institute. Thrombocytopenia.

  8. Kuter DJ. Managing thrombocytopenia associated with cancer chemotherapy. Oncology (Williston Park). 2015;29(4):282-294.

  9. Sunkesula VC, Knighton S, Zabarsky TF, Kundrapu S, Higgins PA, Donskey CJ. Four Moments for Patient Hand Hygiene: A Patient-Centered, Provider-Facilitated Model to Improve Patient Hand Hygiene. Infect Control Hosp Epidemiol. 2015;36(8):986-989. doi:10.1017/ice.2015.78